Clinical Outcomes in Patients With Refractory Anemia With Excess Blasts (RAEB) Who Receive Hypomethylating Agents (HMAs)

Autor: Zeidan, Amer M., Mearns, Elizabeth S., Ng, Carmen D., Shah, Anuj, Lamarre, Neil, Yellow-Duke, Archibong, Alrawashdh, Neda, Yang, Baiyu, Cheng, Wei-Han, Bui, Cat N., Svensson, Anders
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia March 2024 24(3):177-186
Databáze: ScienceDirect
Externí odkaz: